Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis
Clinical trial NCT01818492 · COMPLETED
Trial details
- NCT number
- NCT01818492
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2019-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.